Back to Search Start Over

Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase.

Authors :
Ruf S
Hallur MS
Anchan NK
Swamy IN
Murugesan KR
Sarkar S
Narasimhulu LK
Putta VPRK
Shaik S
Chandrasekar DV
Mane VS
Kadnur SV
Suresh J
Bhamidipati RK
Singh M
Burri RR
Kristam R
Schreuder H
Czech J
Rudolph C
Marker A
Langer T
Mullangi R
Yura T
Gosu R
Kannt A
Dhakshinamoorthy S
Rajagopal S
Source :
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2018 Mar 01; Vol. 28 (5), pp. 922-925. Date of Electronic Publication: 2018 Jan 31.
Publication Year :
2018

Abstract

Nicotinamide N-methyltransferase (NNMT) has been linked to obesity and diabetes. We have identified a novel nicotinamide (NA) analog, compound 12 that inhibited NNMT enzymatic activity and reduced the formation of 1-methyl-nicotinamide (MNA), the primary metabolite of NA by ∼80% at 2 h when dosed in mice orally at 50 mg/kg.<br /> (Copyright © 2018 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1464-3405
Volume :
28
Issue :
5
Database :
MEDLINE
Journal :
Bioorganic & medicinal chemistry letters
Publication Type :
Academic Journal
Accession number :
29433927
Full Text :
https://doi.org/10.1016/j.bmcl.2018.01.058